Category: Joint ventures/collaborations
-
Walgreens, UCSF Partner on Patient Medication Management
26 February 2014. The Walgreens pharmacy chain and University of California in San Francisco are collaborating on new pharmacy services that help patients manage medications to improve their overall health. The company and university are testing this new retail model in a Walgreens store located near the UCSF campus, but financial aspects of the arrangement…
-
Samsung, UCSF to Partner on Mobile Health Care Technologies
21 February 2014. University of California in San Francisco (UCSF) and Samsung Electronics Company are establishing a lab to develop and test new mobile technologies in health care. Financial and intellectual property arrangements for the new UCSF-Samsung Digital Health Innovation Lab were not disclosed. UCSF says mobile health technologies have not yet reached their potential…
-
Vanderbilt, Records Company Partner on Clinical Data Network
21 February 2014. Greenway Medical Technologies in Carrollton, Georgia and Vanderbilt University Medical Center in Nashville are creating a clinical records data network to cover the mid-South region in the U.S. Greenway is a developer of electronic medical and health records. The 18-month project, funded by the Patient Centered Outcomes Research Institute (PCORI), has a…
-
Health Research Collaborative Adds Seven New Members
13 February 2014. Optum Labs, a partnership to increase sharing of solutions and data to improve health care, says seven more organizations from the private, university, and not-for-profit sectors became members of the collaboration. The new participants join current Optum Labs members Optum, a subsidiary of UnitedHealth Group, Mayo Clinic, and AARP. The Optum Labs…
-
Belgium-U.S. Consortium Developing Lung Image Technology
11 February 2014. A group of companies and universities in Belgium and the U.S. are collaborating on an advanced imaging technology to spot signs of lung transplant rejection earlier in a patient’s recovery. Fluidda nv in Kontich, Belgium is leading the collaboration, with additive manufacturing company Materialise in Leuven, Belgium, and universities in Belgium (University…
-
Calif Stem Cell, UC Irvine Partner on Eye Transplant Tissue
6 February 2014. California Stem Cell Inc. in Irvine and University of California in Irvine are researching the creation of retinal tissue from stem cells for transplants in patients with incurable retinal disorders, such as age-related macular degeneration and retinitis pigmentosa. The study is funded by a $4 million grant from the California Institute of…
-
NIH, Pharmas, Non-Profits Partner on Molecular Drug Targets
4 February 2014. National Institutes of Health (NIH), with 10 pharmaceutical companies and 8 not-for-profit organizations, are collaborating on identification of targets at the molecular level for new drugs and diagnostics. The Accelerating Medicines Partnership — a five-year, $230 million initiative — is expected to focus on Alzheimer’s disease, type 2 diabetes, and the autoimmune disorders…
-
Early Trial Finds Vaccine Booster Covers Pandemic Flu Types
30 January 2014. An early-stage clinical trial shows an RNA agent being developed by Hemispherx Biopharma in Philadelphia extends the effectiveness of the standard nasal flu vaccine to cover pandemic influenza strains, like those found in Pacific Rim countries. Results of the trial were presented yesterday at a meeting of the American Society for Microbiology…
-
Mayo Clinic Taking Part in ALS Stem Cell Clinical Trial
29 July 2014. BrainStorm Cell Therapeutics, a biotechnology company in New York and Israel says the Mayo Clinic in Rochester, Minnesota is now taking part in a clinical trial of the company’s treatments for amyotrophic lateral sclerosis (ALS) that harness the patient’s own bone marrow stem cells. Financial aspects of the agreement were not disclosed.…
-
Biopharma, University Partner on Blood Cancer Immunotherapy
29 January 2014. Kiadis Pharma B.V., a biopharmaceutical company in Amsterdam, is collaborating with a research group at Technical University of Munich to identify immune-system cells for treating leukemia in the company’s immunotherapy product for blood cancers. Financial aspects of the partnership were not disclosed, although the company says the Munich research is funded, at…